Phreesia
PHR
10.50
+0.25
+2.44%
Phreesia
US · PHR
#3570 by market cap
Listed 2019
10.50
+0.25
+2.44%
Live - 5344 symbols - heartbeat 517s ago
· 2026-10-08 04:23
Pre-market
10.70
+1.90%
After-hours
10.50
0.00%
- Market cap
- 651.74M
- P/E (TTM)i
- 58.33
- P/Bi
- 1.75
- EPSi
- 0.04
- Div yieldi
- 0.00%
- 52W posi
- 17%
Reader sentiment
Are you bullish or bearish on PHR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.38, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +14.48% YoY
Margins
- Gross margin
- 67.93%
- Operating margin
- -1.38%
- Net margin
- 0.48%
Key ratios & quality
- Enterprise valuei
- 677.14M
- Altman Z-Scorei
- 0.38
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 99.89M | 124.78M | 148.68M | 213.23M | 280.91M | 356.30M | 419.81M | 480.59M |
| Gross profit | 62.89M | 80.06M | 96.29M | 131.85M | 171.64M | 232.29M | 284.88M | 326.47M |
| Selling & admin expenses | 46.44M | 62.82M | 83.43M | 175.10M | 231.65M | 226.93M | 197.73M | 180.15M |
| Research & development | 14.35M | 18.62M | 22.62M | 52.27M | 91.24M | 112.35M | 117.36M | 121.48M |
| Operating profit | -9.49M | -15.30M | -25.67M | -116.82M | -176.55M | -136.48M | -58.10M | -6.61M |
| Pretax profit | -15.06M | -22.07M | -27.24M | -117.98M | -175.66M | -135.34M | -55.81M | -8.94M |
| Tax | 0 | -1.78M | 49.00K | 182.00K | 483.00K | 1.54M | 2.72M | -11.25M |
| Net profit | -15.06M | -20.29M | -27.29M | -118.16M | -176.15M | -136.89M | -58.53M | 2.31M |
| Basic EPS | -25 | -5 | -1 | -2 | -3 | -3 | -1 | 0 |
| Diluted EPS | -24.53 | -4.50 | -0.69 | -2.37 | -3.36 | -2.51 | -1.02 | 0.04 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 115.94M | 117.26M | 120.33M | 127.07M | 130.94M | 129.46M |
| Gross profit | 77.87M | 79.61M | 82.31M | 86.68M | 87.60M | 86.27M |
| Selling & admin expenses | 42.45M | 44.44M | 41.64M | 51.62M | 42.57M | 41.10M |
| Research & development | 31.83M | 29.27M | 29.45M | 30.93M | 28.33M | 27.57M |
| Operating profit | -3.29M | -1.51M | 3.74M | -5.56M | 6.75M | 7.61M |
| Pretax profit | -3.18M | -563.00K | 5.13M | -10.32M | 4.72M | 3.24M |
| Tax | 735.00K | -1.22M | 854.00K | -11.62M | 1.76M | 1.32M |
| Net profit | -3.91M | 654.00K | 4.27M | 1.30M | 2.96M | 1.92M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.07 | 0.01 | 0.07 | 0.02 | 0.05 | 0.03 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 33.32M | 131.54M | 272.27M | 386.35M | 262.44M | 195.68M | 203.29M | 279.84M |
| Cash & ST investments | 1.54M | 90.32M | 218.78M | 313.81M | 176.68M | 87.52M | 84.22M | 73.83M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 59.26M | 158.76M | 326.67M | 494.48M | 370.06M | 370.33M | 388.42M | 663.79M |
| Total current liabilities | 27.93M | 35.35M | 54.99M | 68.43M | 79.04M | 110.12M | 114.02M | 183.24M |
| Short-term debt | 1.97M | 2.32M | 5.95M | 7.10M | 6.11M | 6.45M | 9.01M | 9.23M |
| Long-term debt | 27.92M | 21.54M | 6.47M | 7.42M | -- | 2.05M | 719.00K | 90.00M |
| Total liabilities | 270,236,000.00 | 56,893,000.00 | 63,360,000.00 | 77,196,000.00 | 82,238,000.00 | 118,877,000.00 | 123,607,000.00 | 326,583,000.00 |
| Total equity | -210.97M | 101.87M | 263.31M | 417.28M | 287.82M | 251.45M | 264.81M | 337.21M |
| Retained earnings | -210.99M | -284.49M | -311.78M | -429.94M | -606.08M | -742.97M | -801.50M | -799.19M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 215.41M | 222.64M | 240.91M | 279.84M | 267.26M | 253.50M |
| Cash & ST investments | 90.87M | 98.27M | 106.37M | 73.83M | 74.71M | 72.95M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 400.40M | 408.63M | 423.47M | 663.79M | 666.14M | 646.98M |
| Total current liabilities | 110.72M | 105.14M | 98.78M | 183.24M | 152.11M | 143.84M |
| Short-term debt | 9.31M | 8.04M | 6.95M | 9.23M | 6.36M | 6.11M |
| Long-term debt | 6.16M | 4.58M | 3.35M | 90.00M | 85.30M | 61.17M |
| Total liabilities | 118,209,000.00 | 110,642,000.00 | 103,143,000.00 | 326,583,000.00 | 307,051,000.00 | 275,126,000.00 |
| Total equity | 282.19M | 297.99M | 320.33M | 337.21M | 359.09M | 371.85M |
| Retained earnings | -805.41M | -804.76M | -800.49M | -799.19M | -796.23M | -794.31M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -2.13M | 826.00K | 2.89M | -74.71M | -90.12M | -32.38M | 32.38M | 78.81M |
| Depreciation & amortization | 11.59M | 13.92M | 15.91M | 21.30M | 25.30M | 29.49M | 27.89M | 31.45M |
| Free cash flow | -11.96M | -11.49M | -15.69M | -105.52M | -116.33M | -57.48M | 8.29M | 54.42M |
| Dividends paid | 0 | -14.96M | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 130.78M | 169.84M | 236.82M | -19.38M | -12.18M | 0 | 0 |
| Ending cash balance | 1.54M | 90.32M | 218.78M | 313.81M | 176.68M | 87.52M | 84.22M | 73.83M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 14.85M | 14.84M | 15.47M | 33.66M | 23.92M | 18.33M |
| Depreciation & amortization | 6.88M | 7.41M | 7.48M | 9.69M | 9.95M | 10.00M |
| Free cash flow | 7.46M | 9.63M | 8.80M | 28.53M | 16.37M | 13.82M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 128.00K | 114.00K | -- | -- | -964.00K | -4.00K |
| Ending cash balance | 90.87M | 98.27M | 106.37M | 73.83M | 76.40M | 74.64M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -14.95 | -34.72 | -49.96 | -50.77 | -22.67 | 0.77 |
| ROA %i | -25.58 | -83.87 | -11.24 | -28.78 | -40.75 | -36.98 | -15.43 | 0.44 |
| ROIC %i | -- | -- | -13.53 | -33.03 | -48.47 | -49.44 | -21.53 | 1.43 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -34.62 | -31.47 |
| EBIT margin %i | -9.50 | -12.26 | -17.27 | -54.78 | -62.03 | -37.47 | -12.74 | -0.41 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | 1.98 | 11.32 |
| Current ratioi | 1.19 | 3.72 | 4.95 | 5.65 | 3.32 | 1.78 | 1.78 | 1.53 |
| Quick ratioi | 0.63 | 3.18 | 4.51 | 5.17 | 2.89 | 1.38 | 1.38 | 1.25 |
| Debt / assetsi | 54.48 | 15.03 | 4.38 | 3.20 | 2.48 | 3.24 | 4.58 | 15.43 |
| LT debt / equityi | -- | 21.15 | 3.18 | 2.08 | 1.07 | 2.20 | 3.32 | 27.65 |
| Interest coveragei | -- | -- | -- | -100.44 | -123.50 | -72.00 | -22.78 | -0.29 |
| Revenue CAGR (3Y) %i | -- | -- | 23.03 | 28.76 | 31.06 | 33.82 | 25.33 | 19.60 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | -15.97 | -8.76 | -1.87 | 0.77 | 2.86 | 3.12 |
| ROA %i | -11.06 | -6.24 | -1.35 | 0.44 | 1.72 | 1.98 |
| ROIC %i | -15.00 | -8.42 | -1.96 | 1.43 | 3.50 | 4.17 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -8.64 | -4.69 | -0.49 | -0.41 | 1.57 | 2.54 |
| FCF / sales %i | 5.04 | 6.20 | 7.58 | 11.32 | 12.78 | 13.30 |
| Current ratioi | 1.95 | 2.12 | 2.44 | 1.53 | 1.76 | 1.76 |
| Quick ratioi | 1.50 | 1.67 | 1.97 | 1.25 | 1.43 | 1.44 |
| Debt / assetsi | 3.96 | 3.13 | 2.46 | 15.43 | 13.89 | 10.50 |
| LT debt / equityi | 2.33 | 1.60 | 1.09 | 27.65 | 24.00 | 16.63 |
| Interest coveragei | -16.85 | -10.47 | -1.31 | -0.29 | 0.88 | 1.27 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Technology Solutions segment100.00%
Quote time 2026-10-08 04:23:07 · For reference only, not investment advice and not tailored to your situation.